Lysine pyrrolation is a naturally-occurring covalent modification involved in the production of DNA mimic proteins

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Miyashita, Hiroaki ^a   Chikazawa, Miho ^a   Otaki, Natsuki ^a   Hioki, Yusuke ^a   Shimozu, Yuki ^a   Nakashima, Fumie ^a   Shibata, Takahiro ^a,b   Hagihara, Yoshihisa ^c   Maruyama, Shoichi ^d   Matsumi, Noriyoshi ^e   Uchida, Koji ^a  

^a NAGOYA UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^d NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e JAPAN ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; ETHIDIUM; FLUORESCENT DYE; LYSINE; ORGANIC COMPOUND; PROTEIN; PROTEIN BINDING; PYRROLE DERIVATIVE; SYBR GREEN I;

AMINO ACID SEQUENCE; ANIMAL; BAGG ALBINO MOUSE; CHEMICAL STRUCTURE; CHEMISTRY; FEMALE; HUMAN; IMMUNOBLOTTING; MALE; METABOLISM; MOLECULAR GENETICS; MURPHY ROTHS LARGE LYMPHOPROLIFERATIVE MOUSE; PROTEIN PROCESSING; PROTEIN TERTIARY STRUCTURE; SPECTROFLUOROMETRY; SYSTEMIC LUPUS ERYTHEMATOSUS;

AMINO ACID SEQUENCE; ANIMALS; DNA; ETHIDIUM; FEMALE; FLUORESCENT DYES; HUMANS; IMMUNOBLOTTING; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYSINE; MALE; MICE, INBRED BALB C; MICE, INBRED MRL LPR; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; ORGANIC CHEMICALS; PROTEIN BINDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STRUCTURE, TERTIARY; PROTEINS; PYRROLES; SPECTROMETRY, FLUORESCENCE;

EID: 84902843016     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep05343     Document Type: Article

References (32)

1. Moellering, R. E.&Cravatt, B. F. Functional lysine modification by an intrinsically reactive primary glycolytic metabolite. Science 341, 549-553 (2013).
2. Uchida, K. Role of reactive aldehyde in cardiovascular diseases. Free Radical Biol. Med. 28, 1685-96 (2000). (Pubitemid 30628655)
3. Uchida, K. 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. Prog. Lipid Res. 42, 318-343 (2003). (Pubitemid 36411689)
4. Wuttge, D. M. et al. T-cell recognition of lipid peroxidation products breaks tolerance to self proteins. Immunology. 98, 273-279 (1999). (Pubitemid 29487650)
5. Binder, C. J. & Silverman, G. J. Natural antibodies and the autoimmunity of atherosclerosis. Springer Semin Immunopathol. 26, 385-404 (2005). (Pubitemid 40468892)
6. Stadtman, E. R. Protein oxidation and aging. Science 257, 1220-1224 (1992).
7. Stadtman, E. R.&Levine, R. L. Protein oxidation. Ann.NY Acad. Sci. 899, 191-208 (2000). (Pubitemid 30352787)
8. Kowal, C. L. et al. Molecular mimicry between bacterial and self antigen in a patient with systemic lupus erythematosus. Eur. J. Immunol. 29, 1901-1911 (1999).
9. Limpanasithikul, W. et al. Cross-reactive antibodies have both protective and pathogenic potential. J. Immunol. 155, 967-973 (1995).
10. Chan, T. M. et al. Mesangial cell-binding anti-DNA antibodies in patients with systemic lupus erythematosus. J. Am. Soc. Nephrol. 13, 1219-1229 (2002).
11. Jacob, L. et al. Presence of antibodies against a cell-surface protein, cross-reactive with DNA, in systemic lupus erythematosus: a marker of the disease. Proc. Natl. Acad. Sci. U.S.A. 84, 2956-2959 (1987). (Pubitemid 17064757)
12. Lee, S. H. & Blair, I. A. Characterization of 4-oxo-2-nonenal as a novel product of lipid peroxidation. Chem. Res. Toxicol. 13, 698-702 (2000). (Pubitemid 30663446)
13. Otaki, N. et al. Identification of a lipid peroxidation product as the source of oxidation-specific epitopes recognized by anti-DNA autoantibodies. J. Biol. Chem. 285, 33834-33842 (2010).
14. Witztum, J. L. & Steinberg, D. The oxidative modification hypothesis of atherosclerosis: Does it hold for humans? Trends Cardiovasc. Med. 11, 93-102 (2001). (Pubitemid 33070331)
15. Xu,G.&Sayre, L. M. Structural characterization of a 4-hydroxy-2-alkenal-derived fluorophore that contributes to lipoperoxidation- dependent protein cross-linking in aging and degenerative disease. Chem. Res. Toxicol. 11, 247-251 (1998).
16. Dragan, A. I. et al. SYBR Green I: fluorescence properties and interaction with DNA. J. Fluoresc. 22, 1189-1199 (2012).
17. Carter, D. C. & Ho, J. X. Structure of Serum Albumin. Adv. Protein Chem. 45, 153-203 (1994). (Pubitemid 24139888)
18. Rezwan, K. et al. Bovine serum albumin adsorption onto colloidal Al2O3 particles: A new model based on zeta potential and UV-vis measurements. Langmuir. 20, 10055-10061 (2004).
19. Cosa, G. et al. Photophysical properties of fluorescent DNA-dyes bound to singleand double-stranded DNA in aqueous buffered solution. Photochem. Photobiol. 73, 585-599 (2001).
20. Radic, M. Z.&Weigert, M. Genetic and structural evidence for antigen selection of anti-DNA antibodies. Annu Rev Immunol. 12, 487-520 (1994). (Pubitemid 24140423)
21. Fink, H.-W. & Schönenberger, C. Electrical conduction through DNA molecules. Nature 398, 407-410 (1999). (Pubitemid 29180369)
22. Sayre, L. M. et al. Pyrrole formation from 4-hydroxynonenal and primary amines. Chem. Res. Toxicol. 6, 19-22 (1993). (Pubitemid 23040366)
23. Itakura, K., Osawa, T. & Uchida, K. Structure of a fluorescent compound formed from 4-hydroxy-2-nonenal and Na-hippuryllysine: A model for fluorophores derived from protein modifications by lipid peroxidation. J. Org. Chem. 63, 185-187 (1998).
24. Hidalgo, F. J. & Zamora, R. Fluorescent pyrrole products from carbonyl-amine reactions. J. Biol. Chem. 268, 16190-16197 (1993). (Pubitemid 23229915)
25. Zhang, W.-H. et al.Model studies on protein side chain modification by 4-oxo-2-nonenal. Chem. Res. Toxicol. 16, 512-523 (2003). (Pubitemid 36514509)
26. Salomon, R. G. et al. Levuglandin E2-protein adducts in human plasma and vasculature. Chem. Res. Toxicol. 10, 536-545 (1997). (Pubitemid 27217210)
27. Hidalgo, F. J. & Zamora, R. Epoxyoxoene fatty esters: Key intermediates for the synthesis of long chain pyrrole and furan fatty esters. Chem. Phys. Lipids. 77, 1-11 (1995).
28. Salomon, R. G. et al. HNE-derived 2-pentylpyrroles are generated during oxidation of LDL, are more prevalent in blood plasma from patients with renal disease or atherosclerosis, and are present in atherosclerotic plaques. Chem. Res. Toxicol. 13, 557-564 (2000). (Pubitemid 30491116)
29. Kaur, K. et al. (Carboxyalkyl)pyrroles in human plasma and oxidized low-density lipoproteins. Chem. Res. Toxicol. 10, 1387-1396 (1997). (Pubitemid 28018928)
30. De Montarby, L., Mosset, P. & Gree, R. Sorbic acid iron tricarbonyl complex as resolving agent. Chiral syntheses of 4-hydroxy nonenal and coriolic acid. Tetrahedron Lett. 29, 3895 (1988).
31. Sun, M. et al. Novel bioactive phospholipids: practical total syntheses of products from the oxidation of arachidonic and linoleic esters of 2-lysophosphatidylcholine. J. Org. Chem. 67, 3575-3584 (2002). (Pubitemid 34563966)
32. Zamora, R., Navarro, J. L. & Hidalgo, F. J. Determination of lysine modification product epsilon-N-pyrrolylnorleucine in hydrolyzed proteins and trout muscle microsomes by micellar electrokinetic capillary chromatography. Lipids 30, 477-483 (1995).